Director, Data and Science (Analytic Solutions)
Verana HealthFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Candidates must possess a Ph.D. or M.S. in Biostatistics, Statistics, or a related field, with prior experience in the Biotech/Pharma Industry or a CRO. Required experience includes leading statistical activities for clinical trials across multiple phases, expertise in clinical trial methodology, adaptive designs, and regulatory guidance. Proficiency in SAS, including data simulation and analysis, familiarity with CDISC standards (SDTM/ADaM), and experience with regulatory submissions (NDA/BLA/MAA) are essential. Strong communication and interpersonal skills to explain statistical concepts to non-statisticians, and the ability to work independently in a fast-paced environment are also required.
The Associate Director / Director, Biostatistics will serve as the lead biostatistician for clinical programs or trials from Phase I through Phase III. Responsibilities include providing strategic input into clinical development plans, study designs, and statistical methodologies, and presenting statistical aspects to internal stakeholders. They will develop or review statistical sections of clinical trial protocols, SAPs, and other key documents. The role involves collaborating with internal teams and CROs to oversee statistical programming, analysis, and validation, and interpreting/communicating statistical results to clinical and regulatory stakeholders. Additionally, they will contribute to regulatory submissions, attend meetings with regulatory agencies, ensure statistical deliverables comply with regulatory requirements, identify process improvements, implement innovative statistical solutions, and represent Biostatistics in cross-functional project teams.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.